Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 6/20 | 0.37 |
| ▸ | RXRB | P28702 | 4/20 | 0.37 |
| ▸ | KIF11 | P52732 | 1/20 | 0.34 |
| ▸ | CYP26A1 | O43174 | 3/20 | 0.34 |
| ▸ | CYP26B1 | Q9NR63 | 2/20 | 0.34 |
| ▸ | BACE1 | P56817 | 1/20 | 0.33 |
| ▸ | PTPN22 | Q9Y2R2 | 2/20 | 0.31 |
| ▸ | EPM2A | O95278 | 1/20 | 0.31 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | RARB | P10826 | 3/20 | 0.31 |
| ▸ | RARG | P13631 | 3/20 | 0.31 |
| ▸ | RXRG | P48443 | 3/20 | 0.31 |
| ▸ | RARA | P10276 | 2/20 | 0.31 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.31 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.31 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26000662 | 0.91 | KIF11 (0.34) | KIF11BACE1PTPN22EPM2APTPN2 | |
| SCHEMBL26000659 | 0.91 | RXRA (0.37) | RXRARXRBKIF11CYP26A1CYP26B1 | |
| SCHEMBL12473850 | 0.80 | KIF11 (0.47) | KIF11PTPN22EPM2APTPN2PTPN1 | |
| SCHEMBL26014567 | 0.78 | CYP26A1 (0.33) | RXRARXRBCYP26A1CYP26B1RXRG | |
| SCHEMBL26000566 | 0.78 | GPR3 (0.48) | RXRARXRBPTPN22RARBRARG | |
| SCHEMBL24604645 | 0.77 | KIF11 (0.42) | KIF11PTPN22EPM2APTPN2PTPN1 | |
| SCHEMBL29760999 | 0.76 | NPC1 (0.35) | RXRARXRBCYP26A1CYP26B1KMT2A | |
| SCHEMBL31488770 | 0.76 | KIF11 (0.55) | RXRARXRBKIF11CYP26A1CYP26B1 | |
| SCHEMBL13467815 | 0.74 | KIF11 (0.37) | KIF11PTPN22EPM2APTPN2PTPN1 | |
| SCHEMBL30569510 | 0.74 | HIF1A (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807616-B2 | Organic compound, and electronic element and electronic device using same | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-11-07 | — | — | US | disclosed |
| US-11807616-B2 | Organic compound, and electronic element and electronic device using same | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-11-07 | — | — | US | disclosed |
| US-20230265063-A1 | ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-08-24 | — | — | US | disclosed |
| US-20230265063-A1 | ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230265063-A1 | ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | PIEZO1, OR10J3, OR51E2 | RXRA 2012/4885RXRB 2635/4885KIF11 3022/4885 |
| US-11807616-B2 | Organic compound, and electronic element and electronic device using same | PIEZO1, OR10J3, OR51E2 | RXRA 2012/4885RXRB 2635/4885KIF11 3022/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.